midazolam has been researched along with ziprasidone in 18 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 5 (27.78) | 29.6817 |
2010's | 13 (72.22) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
Alelyunas, YW; Bui, K; Empfield, JR; McCarthy, D; Pelosi-Kilby, L; Shen, C; Spreen, RC | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Biros, M; Clinton, J; Martel, M; Miner, J; Sterzinger, A | 1 |
Gresham, C; Ruha, AM | 1 |
BaldaƧara, L; Cordeiro, DC; Jackoswski, AP; Sanches, M | 1 |
Erdur, B; Ergin, A; Kortunay, S; Yuksel, A | 1 |
Cole, JB; Collins, JD; Driver, BE; Fagerstrom, E; Hessel, M; Horton, GB; Klein, LR; Martel, ML; Miner, JR; Satpathy, R | 1 |
Dickert, NW; Sugarman, J | 2 |
Nordstrom, K; Wilson, M; Zeller, S | 1 |
Cole, JB; Driver, BE; Klein, LR; Martel, ML; Miner, JR | 2 |
April, MD; De Lorenzo, RA; Schauer, SG; Wheeler, AR | 1 |
1 review(s) available for midazolam and ziprasidone
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 trial(s) available for midazolam and ziprasidone
Article | Year |
---|---|
Management of acute undifferentiated agitation in the emergency department: a randomized double-blind trial of droperidol, ziprasidone, and midazolam.
Topics: Adolescent; Adult; Aged; Anti-Anxiety Agents; Antipsychotic Agents; Dose-Response Relationship, Drug; Double-Blind Method; Droperidol; Emergency Service, Hospital; Female; Humans; Length of Stay; Male; Mental Status Schedule; Midazolam; Middle Aged; Piperazines; Prospective Studies; Psychomotor Agitation; Respiratory Insufficiency; Thiazoles; Treatment Outcome | 2005 |
Rapid tranquilization for agitated patients in emergency psychiatric rooms: a randomized trial of olanzapine, ziprasidone, haloperidol plus promethazine, haloperidol plus midazolam and haloperidol alone.
Topics: Adult; Aggression; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Double-Blind Method; Drug Therapy, Combination; Emergency Services, Psychiatric; Female; Haloperidol; Humans; Hypnotics and Sedatives; Injections, Intramuscular; Male; Midazolam; Olanzapine; Piperazines; Promethazine; Psychomotor Agitation; Psychotic Disorders; Thiazoles; Tranquilizing Agents | 2011 |
15 other study(ies) available for midazolam and ziprasidone
Article | Year |
---|---|
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate.
Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility | 2010 |
Respiratory failure following isolated ziprasidone ingestion in a toddler.
Topics: Accidents; Antipsychotic Agents; Chromatography, Liquid; Humans; Hypnotics and Sedatives; Infant; Intubation, Intratracheal; Male; Mass Spectrometry; Midazolam; Piperazines; Respiration, Artificial; Respiratory Insufficiency; Thiazoles; Treatment Outcome | 2010 |
Assessment of propofol, midazolam and ziprasidone, or the combinations for the prevention of acute cocaine toxicity in a mouse model.
Topics: Animals; Anticonvulsants; Antipsychotic Agents; Cocaine-Related Disorders; Disease Models, Animal; Dopamine Antagonists; Drug Therapy, Combination; GABA Modulators; Male; Mice; Midazolam; Piperazines; Propofol; Seizures; Serotonin Antagonists; Thiazoles | 2013 |
Intramuscular Midazolam, Olanzapine, Ziprasidone, or Haloperidol for Treating Acute Agitation in the Emergency Department.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antipsychotic Agents; Cohort Studies; Emergency Medical Services; Female; Haloperidol; Humans; Injections, Intramuscular; Male; Mental Status and Dementia Tests; Midazolam; Middle Aged; Olanzapine; Piperazines; Prospective Studies; Psychomotor Agitation; Thiazoles; Treatment Outcome; Young Adult | 2018 |
Ethics and Regulatory Barriers to Research in Emergency Settings.
Topics: Emergency Service, Hospital; Haloperidol; Midazolam; Olanzapine; Piperazines; Thiazoles | 2018 |
Intramuscular Midazolam, Olanzapine, Ziprasidone, or Haloperidol for Treating Acute Agitation.
Topics: Emergency Service, Hospital; Haloperidol; Midazolam; Olanzapine; Piperazines; Thiazoles | 2019 |
In reply.
Topics: Emergency Service, Hospital; Haloperidol; Midazolam; Olanzapine; Piperazines; Thiazoles | 2019 |
Acute Agitation and the Exception From Informed Consent Requirements.
Topics: Emergency Service, Hospital; Haloperidol; Informed Consent; Midazolam; Olanzapine; Piperazines; Thiazoles | 2019 |
In reply.
Topics: Emergency Service, Hospital; Haloperidol; Midazolam; Olanzapine; Piperazines; Thiazoles | 2019 |
In reply.
Topics: Emergency Service, Hospital; Haloperidol; Midazolam; Olanzapine; Piperazines; Thiazoles | 2019 |